Ketolides lack inducibility properties of MLS(B) resistance phenotype

Journal of Antimicrobial Chemotherapy

Volumn 40, Issue 1, 1997, Pages 85-90

  Bonnefoy, A ^a   Girard, A M ^a   Agouridas, C ^a   Chantot, J F ^a  

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; KETOLIDE; MACROLIDE; ROKITAMYCIN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; NONHUMAN; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; ERYTHROMYCIN; KETOLIDES; KINETICS; MACROLIDES; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS;

EID: 0030742843     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/40.1.85     Document Type: Article

References (11)

1. Jones, W. F., Nichols, R. L. & Finland, M. (1956). Development of resistance and cross-resistance in vitro to erythromycin, carbomycin, spiramycin, oleandomycin and streptogramin. Proceedings of the Society for Experimental Biology and Medicine 93, 388-93.
2. Weisblum, B. (1985). Inducible resistance to macrolides, lincosamides and streptogramin type B antibiotics: the resistance phenotype, its biological diversity, and structural elements that regulate expression. A review. Journal of Antimicrobial Chemotherapy 16, Suppl. A, 63-90.
3. Moazed, D. & Noller, H. F. (1987). Chloramphenicol, erythromycin, carbomycin and vernamycin B protect overlapping sites in the peptidyl transferase region of 23S ribosomal RNA. Biochimie 69, 879-84.
4. Weisblum, B., Siddhikol, C., Lai, C. J. & Demohn, V. (1971). Erythromycin-inducible resistance in Staphylococcus aureus: requirements for induction. Journal of Bacteriology 106, 835-47.
5. Weisblum, B. (1995). Insights into erythromycin action from studies of its activity as inducer of resistance. Antimicrobial Agents and Chemotherapy 39, 797-805.
6. Agouridas, C., Bonnefoy, A. & Chantot, J. F. (1994). Ketolides, a new distinct semi-synthetic class of macrolides: in-vitro and in-vivo antibacterial activities. In Program and Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, FL, 1994. Abstract F168, p. 227. American Society for Microbiology, Washington, DC.
7. Hyder, S. L. & Streitfeld, M. M. (1973). Inducible and constitutive resistance to macrolide antibiotics and lincomycin in clinically isolated strains of Streptococcus pyogenes. Antimicrobial Agents and Chemotherapy 4, 327-31.
8. Arthur, M., Brisson-Noel, A. & Courvalin, P. (1987). Origin and evolution of genes specifying resistance to macrolide, lincosamide and streptogramin antibiotics: data and hypotheses. Journal of Antimicrobial Chemotherapy 20, 783-802.
9. Allen, N. E. (1977). Macrolide resistance in Staphylococcus aureus: inducers of macrolide resistance. Antimicrobial Agents and Chemotherapy 11, 669-74.
10. Horodniceanu, T., Bougueleret, L. & Delbos, F. (1980). Phenotypic aspects of resistance to macrolide and related antibiotics in β-haemolytic group A, B, C and G streptococci. In Recent Developments in Laboratory Identification Techniques (Facklam, R., Laurell, G. & Lind, I., Eds), pp. 122-31. Excerpta Medica, Amsterdam.
11. Agouridas, C., Bonnefoy, A. & Chantot, J. F. (1995). In vitro antibacterial activity of RU 004, a novel ketolide highly active against respiratory pathogens. In Program and Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1995. Abstract F158, p. 140. American Society for Microbiology, Washington, DC.